Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Secondary Prophylaxis of HE in HCV Cirrhosis
NCT04736836Phase 4Completed
- Sponsor
- National Hepatology and Tropical Medicine Research Institute
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rifaximin in hepatic encephalopathy (HE), sponsored by National Hepatology and Tropical Medicine Research Institute. Started Jan 2015; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT04736836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04736836.